ProAxsis is a commercial medtech company, with a focus on respiratory diagnostics.
Products:
ProAxsis has developed a range of products incorporating their patented technology aiding the identification of Active proteases – validated biomarkers of disease activity.
- ProteaseTag ® Active Neutrophil Elastase Immunoassay
- NEATstik ®
- ProteaseTag ® Active Proteinase 3 Immunoassay
Clinical Services and R&D Projects:
ProAxsis offer a range of contract services from protease biomarker investigation, clinical trial and pharma services to academic support services
- All assays as a Service
- Clinical trial and/or development needs
- Assay development and customization
- Bespoke and tailored R&D Projects
Licensing agreements with organisations and pharmaceutical companies, including:
- Astra Zeneca (research use COVID serology testing)
- University of Geneva and University Hospital of Geneva (immunoassay “ELISA” for bone health & osteoporosis)
